Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Emerging concepts in liquid biopsies.

Samantha Perakis1, Michael R Speicher2,3

  • 1Institute of Human Genetics, Medical University of Graz, Harrachgasse 21/8, A-8010, Graz, Austria.

BMC Medicine
|April 7, 2017
PubMed
Summary

Liquid biopsies analyze circulating tumor DNA and cells for minimally invasive tumor genome characterization. This review explores current technologies and future potential for precision medicine applications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

cfDNA UniFlow: a unified preprocessing pipeline for cell-free DNA data from liquid biopsies.

GigaScience·2024
Same author

LBFextract: Unveiling transcription factor dynamics from liquid biopsy data.

Computational and structural biotechnology journal·2024
Same author

GCparagon: evaluating and correcting GC biases in cell-free DNA at the fragment level.

NAR genomics and bioinformatics·2023
Same author

STAT3/LKB1 controls metastatic prostate cancer by regulating mTORC1/CREB pathway.

Molecular cancer·2023
Same author

How to detect cancer early using cell-free DNA.

Cancer cell·2022
Same author

A clinician's handbook for using ctDNA throughout the patient journey.

Molecular cancer·2022

Area of Science:

  • Oncology
  • Genomics
  • Translational Medicine

Background:

  • Precision medicine aims to improve patient outcomes through tailored treatments.
  • Tumors release biomolecules into circulation, offering a window into tumor biology.
  • Liquid biopsies provide a minimally invasive approach to access tumor-derived material.

Purpose of the Study:

  • To review current technologies for liquid biopsy analysis.
  • To explore emerging concepts and future directions in the field.
  • To discuss the clinical readiness of liquid biopsies for routine practice.

Main Methods:

  • Analysis of circulating tumor cells (CTCs).
  • Detection of circulating tumor DNA (ctDNA).
  • Characterization of tumor-derived exosomes.
Keywords:
Cell-free DNACirculating tumor DNACirculating tumor cellsDisease monitoringLiquid biopsyPrecision medicine

Related Experiment Videos

Main Results:

  • Molecular information from parent tumors can be extracted from liquid biopsy components.
  • Current technologies enable tumor genome characterization via blood samples.
  • Emerging concepts promise to advance the capabilities of liquid biopsies.

Conclusions:

  • Liquid biopsies hold significant potential for improving precision medicine.
  • Understanding mutation levels and technological limitations is crucial.
  • The clinical utility of liquid biopsies in routine practice requires further evaluation.